Status:
COMPLETED
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Fatigue
Leukemia
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
RATIONALE: Supportive care, such as healing touch, may improve quality of life in patients receiving chemotherapy for acute leukemia. PURPOSE: This clinical trial is studying how well healing touch w...
Detailed Description
OBJECTIVES: * Determine the feasibility of conducting a randomized controlled trial, in terms of recruiting and retaining participants, to a study of healing touch (HT) as supportive care in patients...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of one of the following acute leukemias:
- Acute lymphocytic leukemia
- Acute myeloid leukemia
- Hospitalized for induction (newly diagnosed patients) or reinduction (relapsed patients) chemotherapy
- Must be oncology inpatients at Wake Forest University Baptist Medical Center
- PATIENT CHARACTERISTICS:
- Must know adequate English to understand the consent form, complete questionnaires, and converse with study staff
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00321880
Start Date
February 1 2006
End Date
October 1 2008
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157-1096